Breast Ultrasound Market Outlook

Global Breast Ultrasound Market Size - By Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2035

Published: May-2026 Report ID: MEDE2623 Pages: 1 - 250 Formats*:     
Category : Medical Devices
According to SPER Market Research, the Global Breast Ultrasound Market is estimated to reach USD 7.94 billion by 2035 with a CAGR 8.54%.

Introduction and Overview
The report includes an in-depth analysis of the Global Breast Ultrasound Market, including market size and trends, product mix, Applications, and supplier analysis.

The global Breast Ultrasound Market reached USD 3.5 billion in 2025 and achieved a CAGR of 8.54%. The breast ultrasound systems market is growing steadily due to the increasing prevalence of breast cancer, rising awareness, supportive government initiatives, and technological advancements. Breast cancer remains the most commonly diagnosed cancer globally, driving the need for early and accurate detection methods. Breast ultrasound systems are widely preferred because they are non-invasive, radiation-free, and effective for routine screenings and follow-ups. Growing awareness campaigns and national screening programs are encouraging regular check-ups, while governments are improving healthcare accessibility through subsidies and infrastructure investments. Additionally, emerging economies are adopting portable and AI-enabled ultrasound devices, further boosting market expansion and improving patient outcomes worldwide.

By Type:
The automated breast ultrasound segment holds a dominant position in the market due to its advanced imaging capabilities and improved diagnostic accuracy. Automated Breast Ultrasound Systems provide high-resolution three-dimensional images, ensuring standardized and consistent screening, especially for women with dense breast tissue, where mammography may be less effective. Compared to conventional systems, automated solutions reduce operator dependency, minimize human error, and improve workflow efficiency in hospitals and diagnostic centers. Growing awareness of early breast cancer detection, increasing screening programs, and continuous technological advancements by major healthcare companies are further driving the adoption of automated breast ultrasound systems worldwide.
 
By End Use: 
Hospitals dominate the breast ultrasound market as they serve as the primary centers for breast cancer screening, diagnosis, and follow-up care. These facilities offer access to advanced conventional and automated ultrasound systems, skilled radiologists, and specialized imaging units that improve diagnostic accuracy, particularly for women with dense breast tissue. The adoption of AI-powered ultrasound platforms and cloud-based imaging technologies is further enhancing workflow efficiency, lesion detection, and remote consultations. Growing investments in healthcare infrastructure, early detection programs, and integrated care models continue to strengthen hospitals’ position as the leading end users in the breast ultrasound market.

Regional Insights:
North America holds a leading share in the breast ultrasound market due to advanced healthcare infrastructure, rising breast cancer prevalence, and rapid adoption of innovative imaging technologies. The United States drives regional growth with increasing demand for accurate, non-invasive diagnostic solutions, particularly for women with dense breast tissue. Hospitals and diagnostic centers are increasingly adopting automated and AI-powered ultrasound systems to improve detection accuracy and workflow efficiency. In Europe, growing breast cancer cases, supportive awareness programs, and government initiatives are accelerating the adoption of breast ultrasound systems, including portable and automated technologies, for early detection and improved patient outcomes.

Market Competitive Landscape:
The Global Breast Ultrasound Market is highly consolidated. Some of the market key players are CapeRay, Delphinus Medical Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, Fukuda Denshi, Hologic, Inc., Seno Medical Instruments Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Samsung Electronics Co. Ltd., and FujiFilm Holdings Corporation.

Recent Developments:
  • In October 2021, Delphinus Medical Technologies, Inc. received U.S. FDA approval for its SoftVue three-dimensional whole breast ultrasound system, creating strong growth opportunities in breast cancer screening.

Scope of the report:
Report MetricDetails
Market size available for years2022-2035
Base year considered2025
Forecast period2026-2035
Segments coveredBy Type, By End Use
Regions coveredNorth America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies CoveredCapeRay, Delphinus Medical Technologies, Inc., GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, Fukuda Denshi, Hologic, Inc., Seno Medical Instruments Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Samsung Electronics Co., Ltd., FujiFilm Holdings Corporation.


Key Topics Covered in the Report
  • Global Breast Ultrasound Market Size (FY’2022-FY’2035)
  • Overview of the Global Breast Ultrasound Market
  • Segmentation of the Global Breast Ultrasound Market by Type (Conventional ultrasound, Automated ultrasound)
  • Segmentation of the Global Breast Ultrasound Market by End Use (Hospitals, Diagnostic Laboratories, Other end users)
  • Statistical Snap of the Global Breast Ultrasound Market
  • Expansion Analysis of the Global Breast Ultrasound Market
  • Problems and Obstacles in the Global Breast Ultrasound Market 
  • Competitive Landscape in the Global Breast Ultrasound Market
  • Details on Current Investment in the Global Breast Ultrasound Market
  • Competitive Analysis of the Global Breast Ultrasound Market 
  • Prominent Players in the Global Breast Ultrasound Market
  • SWOT Analysis of the Global Breast Ultrasound Market
  • Global Breast Ultrasound Market Future Outlook and Projections (FY’2026-FY’2035)
  • Recommendations from Analyst  

1. Introduction
1.1 Scope of the report
1.2  Market segment analysis

2. Research Methodology 
2.1 Research data source
2.1.1 Secondary Data
2.1.2 Primary Data
2.1.3 SPER’s internal Database
2.1.4 Primary insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1 Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges

5. Market variable and outlook
5.1 SWOT Analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2 PESTEL Analysis
5.2.1 Political Landscape
5.2.2 Economic Landscape
5.2.3 Social Landscape
5.2.4 Technological Landscape
5.2.5 Environmental Landscape
5.2.6 Legal Landscape
5.3 PORTER’s Five Forces
5.4 Heat Map Analysis

6. Competitive Landscape
6.1. Global Breast Ultrasound Market Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Breast Ultrasound Market

7. Global Breast Ultrasound Market, By Type, (USD Million) 2022-2035
7.1 Conventional ultrasound
7.2 Automated ultrasound       

8. Global Breast Ultrasound Market, By End Use, (USD Million) 2022-2035
8.1 Hospitals
8.2 Diagnostic Laboratories
8.3 Other end users 

9. Global Breast Ultrasound Market, (USD Million) 2022-2035
9.1 Global Breast Ultrasound Market Size and Market Share

10.  Global Breast Ultrasound Market, By Region, 2022-2035 (USD Million)
10.1 Asia-Pacific
10.1.1 Australia
10.1.2 China
10.1.3 India
10.1.4 Japan
10.1.5 South Korea
10.1.6 Rest of Asia-Pacific
10.2 Europe
10.2.1 France
10.2.2 Germany 
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Middle East and Africa
10.3.1 Kingdom of Saudi Arabia
10.3.2 United Arab Emirates
10.3.3 Qatar
10.3.4 South Africa
10.3.5 Egypt
10.3.6 Morocco
10.3.7 Nigeria
10.3.8 Rest of Middle-East and Africa
10.4 North America
10.4.1 Canada 
10.4.2 Mexico
10.4.3 United States
10.5 Latin America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Rest of America

11. Company Profile  
11.1 CapeRay
11.1.1 Company details
11.1.2 Financial outlook
11.1.3 Product summary
11.1.4 Recent developments
11.2 Delphinus Medical Technologies, Inc.
11.2.1 Company details
11.2.2 Financial outlook
11.2.3 Product summary
11.2.4 Recent developments
11.3 GE Healthcare
11.3.1 Company details
11.3.2 Financial outlook
11.3.3 Product summary
11.3.4 Recent developments
11.4 Koninklijke Philips N.V.
11.4.1 Company details
11.4.2 Financial outlook
11.4.3 Product summary
11.4.4 Recent developments
11.5 Siemens Healthineers AG
11.5.1 Company details
11.5.2 Financial outlook
11.5.3 Product summary
11.5.4 Recent developments
11.6 Canon Medical Systems Corporation
11.6.1 Company details
11.6.2 Financial outlook
11.6.3 Product summary
11.6.4 Recent developments
11.7 Fukuda Denshi
11.7.1 Company details
11.7.2 Financial outlook
11.7.3 Product summary
11.7.4 Recent developments
11.8 Hologic, Inc.
11.8.1 Company details
11.8.2 Financial outlook
11.8.3 Product summary
11.8.4 Recent developments
11.9 Seno Medical Instruments Inc.
11.9.1 Company details
11.9.2 Financial outlook
11.9.3 Product summary
11.9.4 Recent developments
11.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.10.1  Company details
11.10.2  Financial outlook
11.10.3  Product summary
11.10.4  Recent developments
11.11 Samsung Electronics Co. Ltd.
11.11.1  Company details
11.11.2  Financial outlook
11.11.3  Product summary
11.11.4  Recent developments
11.12 FujiFilm Holdings Corporation
11.12.1  Company details
11.12.2  Financial outlook
11.12.3  Product summary
11.12.4  Recent developments
11.13 Others

12. Conclusion

13. List Of Abbreviations 

14. Reference Links



SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
PLACE AN ORDER
  • 15 % off
     
    $ 3250
  • 20 % off
             
    $ 4250
  • 25 % off
         
    $ 6250
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis
Thought Leadership

Trusted by Industry Leaders

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-Danaher
SPER-AandM
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken
HIPPA Compliant
GDPR Certified
ISO 27001
Peer Reviewed
Get Started Today

Your Competitive Advantage in
Pharmaceutical & Medical Technology
Markets

Join industry leaders leveraging AI-powered intelligence to make confident, data-driven decisions that accelerate breakthrough treatments and technologies to market.

No Credit Card Required
15-Minute Demo
Expert Guidance